Hisashi Yamanaka
16PUBLICATIONS
51CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Jan 21, 2026
Efficacy and Safety of Tofacitinib and Adalimumab in Rheumatoid Arthritis by Body Mass Index-Normalized Methotrexate Dose: A Post Hoc Analysis.Tsutomu Takeuchi, Yoshiya Tanaka, Hisashi Yamanaka
|Jul 27, 2024
Methotrexate, Tofacitinib, and Biologic Disease-Modifying Antirheumatic Drug Safety and Effectiveness Among Patients with Rheumatoid Arthritis in Japan: CorEvitas Registry Observational Study.Yoshiya Tanaka, Mitsumasa Kishimoto, Koshiro Sonomoto
|Jul 17, 2024
Incidence of Malignancies and the Association with Biological Disease-Modifying Antirheumatic Drugs in Japanese Patients with Rheumatoid Arthritis: A Time-Dependent Analysis from the IORRA Patient Registry.Masayoshi Harigai, Eiichi Tanaka, Eisuke Inoue
|Sep 21, 2023
Factors associated with sarcopenia in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study.Masanori Nakayama, Takefumi Furuya, Eisuke Inoue
|Mar 17, 2022
Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication.Yutaka Kawahito, Akio Morinobu, Yuko Kaneko
Pageof 3
Frequent Collaborators
9 joint publications
Masayoshi Harigai
7 joint publications
Eiichi Tanaka
5 joint publications
Eisuke Inoue
4 joint publications
Mitsumasa Kishimoto
4 joint publications
Takefumi Furuya
4 joint publications
Katsunori Ikari
3 joint publications
Masataka Kohno
3 joint publications
Shintaro Hirata
3 joint publications
Yutaka Kawahito
3 joint publications
Yoshiya Tanaka
